Kairos Pharma, LTD. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2023 to Q3 2024
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
Kairos Pharma, LTD. annual/quarterly Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2023 to Q3 2024.
- Kairos Pharma, LTD. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 10.9M shares, a 5.57% increase year-over-year.
- Kairos Pharma, LTD. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 11.4M shares, a 9.38% increase from 2023.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)